CCL2 and neoplasm: It was shown that DNMT1-mediated DNA methylation and EZH2-mediated H3K27me3, in the enhancer region, suppressed CCL2 expression in SCLC cells, thereby enhancing tumor progression (Zheng et al., 2021).